POSSIBILITIES OF USING PROBIOTICS FOR HELICOBACTER PYLORI ERADICATION: MAASTRICHT V CONSENSUS CONFERENCE RECOMMENDATIONS
Issue:
1
Year:
2017
The new European consensus for the management of patients with Helicobacter pylori (Hp)-associated diseases draws attention to the fact that the stomach has a large number of microorganisms that can influence the development of abnormalities. The use of probiotics contributes to a reduction in the incidence of side effects and enhances the effectiveness of Hp eradication.
Keywords:
gastroenterology
Helicobacter pylori
microbiota
eradication
probiotics
consensus
References:
- Malfertheiner P., Megraud F., O'Morain C.A. et al. Management of Helicobacter pylori infection-the Maastricht V / Florence Consensus Report // Gut. – 2017; 66 (1): 6–30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.
- Bik E., Eckburg P., Gill S. et al. Molecular analysis of the bacterial microbiota in the human stomach // Proc. Natl. Acad. Sci. USA. – 2006; 103 (3): 732–7.
- Cao L., Yu J. Effect of Helicobacter pylori Infection on the Composition of Gastric Microbiota in the Development of Gastric Cancer // Gastrointest. Tumors. – 2015; 2 (1): 14–25.
- Khosravi Y., Dieye Y., Poh B. et al. Culturable bacterial microbiota of the stomach of Helicobacter pylori positive and negative gastric disease patients // Sci. World J. – 2014; 2014: 610421.
- Sheh A., Fox J. The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis // Gut Microbes. – 2013; 4 (6): 505–31.
- Butorin N.N., Bichurina T.B., Tsukanov V.V. i dr. Rasprostranennost' i klinicheskie aspekty pischevoda Barretta u naselenija Vostochnoj Sibiri // Ter. arh. – 2013; 1: 62–5.
- Tsukanov V.V., Tret'jakova O.V., Amel'chugova O.S. i dr. Rasprostranennost' atroficheskogo gastrita tela zheludka u naselenija g. Krasnojarska starshe 45 let // Ros. zhurn. gastroenterol., gepatol., koloproktol. – 2012; 4: 27–31.
- Tsukanov V.V., Seliverstova E.V., Dogadin S.A. Pokazateli lipidnogo sostava syvorotki krovi i zhelchi pri zabolevanijah zhelchevyvodjaschih putej u bol'nyh saharnym diabetom // Ter. arh. – 2005; 2: 15–8.
- Ageeva E.S., Shtygasheva O.V., Tsukanov V.V. i dr. Immunologicheskie osobennosti techenija gastroduodenal'noj patologii u zhitelej Hakasii // Immunologija. – 2009; 3: 162–4.
- Ageeva E.S., Shtygasheva O.V., Rjazantseva N.V. i dr. Molekuljarno-geneticheskie faktory, vlijajuschie na ishod infitsirovanija Helicobacter pylori u zhitelej Respubliki Hakasija // Ros. zhurn. gastroenterol., gepatol., koloproktol. – 2010; 4: 16–21.
- Dicksved J., Lindberg M., Rosenquist M. et al. Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls // J. Med. Microbiol. – 2009; 58 (Pt. 4): 509–16.
- Eun C., Kim B., Han D. et al. Differences in gastric mucosal microbiota profiling in patients with chronic gastritis, intestinal metaplasia, and gastric cancer using pyrosequencing methods // Helicobacter. – 2014; 19 (6): 407–16.
- Lofgren J., Whary M., Ge Z. et al. Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia // Gastroenterology. – 2011; 140 (1): 210–20.
- Jernberg C., Löfmark S., Edlund C. et al. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota // ISME J. – 2007; 1 (1): 56–66.
- Ladirat S., Schols H., Nauta A. et al. High-throughput analysis of the impact of antibiotics on the human intestinal microbiota composition // J. Microbiol. Methods. – 2013; 92 (3): 387–97.
- Engelbrektson A., Korzenik J., Pittler A. et al. Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy // J. Med. Microbiol. – 2009; 58 (Pt. 5): 663–70.
- Lv Z., Wang B., Zhou X. et al. Efficacy and safety of probiotics as adjuvant agents for Helicobacter pylori infection: A metaanalysis // Exp. Ther. Med. – 2015; 9 (3): 707–16.
- Szajewska H., Horvath A., Piwowarczyk A. Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment // Aliment. Pharmacol. Ther. – 2010; 32 (9): 1069–79.
- Zhang M., Qian W., Qin Y. et al. Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis // World J. Gastroenterol. – 2015; 21 (14): 4345–57.
- Marshall B., Warren J. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration // Lancet. – 1984; 1 (8390): 1311–5.
- Tsukanov V.V., Kasparov E.V., Vasjutin A.V. i dr. Mikrobiom zheludka: razvitie revoljutsii // Farmateka. – 2016: 15: 78–81.
- Sugano K., Tack J., Kuipers E. et al. Kyoto global consensus report on Helicobacter pylori gastritis // Gut. – 2015; 64 (9): 1353–67.